Compounded GLP-1 medications occupy a different regulatory category than FDA-approved brand-name drugs, and individual results vary depending on adherence, dosage, diet, activity, and individual physiology
This epigenetic alteration results in cancer progression, drug resistance [34], metastasis and stemness induction [35, 36], metabolic alterations by affecting enzymes involved in the tricarboxylic acid cycle (TCA), and carbohydrate, amino acid, fatty acid, and nucleotide metabolism [35], hence opening the way to the generation of novel therapeutic strategies against lysine lactylation, not only regarding histones (Fig
Retatrutide adds GIP and glucagon signaling, but the Phase 3 side-effect list still looks recognizably incretin-based
Cost, not evidence, set where the community landed
That responsibility starts with the reconstitution process
This deficiency restricts tissue uptake, leading to decreased accumulation in the heart and skeletal muscle and potentiates increased renal carnitine loss [21, 22] leading to systemic carnitine depletion [23]